Georgia vs Moldova: The number of people with susceptibility test result for rifampicin
Georgia
953
in 2021
Moldova
991
in 2021
Georgia rank
68th
Moldova rank
67th
The number of people with susceptibility test result for rifampicin over time
- Georgia
- Moldova
How they compare
Moldova currently reports 991 against 953 in Georgia, a difference of 38.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Moldova ahead.
Georgia ranks 68th and Moldova ranks 67th of 155 countries.
Across the 2 decades both report, Georgia averaged higher in 1 and Moldova in 1.
Head to head by decade
| Decade | Georgia | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,372 | 1,394 | 22.67 | Moldova |
| 2020s | 1,008 | 915.5 | 93 | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Georgia or Moldova?
- Moldova, at 991 against 953 in Georgia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Georgia and Moldova?
- 38, with Moldova ahead.
- How many years of comparable data are there for Georgia and Moldova?
- 5 years are reported by both, from 2017 to 2021.
- How do Georgia and Moldova rank globally for the number of people with susceptibility test result for rifampicin?
- Georgia ranks 68th and Moldova ranks 67th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.